Results
RxSight Lowers Sales Guidance, Shares Fall 12.9%
RxSight Inc. cut its full‑year 2026 sales outlook to $110‑$120 million, down from $120‑$135 million, prompting a 12.9% share decline.
Total 2026 revenue guidance now $140‑$160 million, including $30‑$
